NFKB1 and neoplasm: Our recent studies showed that bortezomib can also increase the cytoplasmic and nuclear phosphorylation of NFκB p65 in CD8+T cells while maintaining IFNγ secretion to improve FasL-mediated tumor lysis [7, 33].